{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:45:10Z","timestamp":1777355110834,"version":"3.51.4"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.567856","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T06:54:20Z","timestamp":1599807260000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case Report: Hyper IgM Syndrome Identified by Whole Genome Sequencing in a Young Syrian Man Presenting With Atypical, Severe and Recurrent Mucosal Leishmaniasis"],"prefix":"10.3389","volume":"11","author":[{"given":"Camilla Heldbjerg","family":"Drabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasmus L.","family":"Marvig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line","family":"Borgwardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens D.","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne Vibeke Hansen","family":"Maquart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terese Lea","family":"Katzenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Helleberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency.","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B2","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European society for immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity.","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders.","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/cei.12178","article-title":"New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin.","volume":"174","author":"Ameratunga","year":"2013","journal-title":"Clin Exp Immunol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee.","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol."},{"key":"B6","year":"2019","journal-title":"Leishmaniasis."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00330","article-title":"Leishmania spp-host interaction: there is always an onset, but is there an end?","volume":"9","author":"Concei\u00e7\u00e3o-Silva","year":"2019","journal-title":"Front Cell Infect Microbiol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006375","article-title":"New insights into leishmaniasis in the immunosuppressed.","volume":"12","author":"Akuffo","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01308","article-title":"The binomial parasite-host immunity in the healing process and in reactivation of human tegumentary leishmaniasis.","volume":"9","author":"Concei\u00e7\u00e3o-Silva","year":"2018","journal-title":"Front Microbiol."},{"key":"B10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis.","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet."},{"key":"B11","article-title":"Leishmania tropica med atypisk, mukokutan manifestation hos en flygtning.","volume":"180","author":"M\u00f8ller","year":"2018","journal-title":"Ugeskrift Laeger."},{"key":"B12","first-page":"223","article-title":"Visceral leishmaniasis in a patient with common variable immunodeficiency and evans syndrome: clinical remarks.","volume":"32","author":"Maio","year":"2009","journal-title":"New Microbiol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02678","article-title":"All patients with common variable immunodeficiency disorders (CVID) should be routinely offered diagnostic genetic testing.","volume":"10","author":"Ameratunga","year":"2019","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med Off J Am Coll Med Genet."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00130","article-title":"A novel de novo mutation in the CD40 ligand gene in a patient with a mild X-linked hyper-IgM phenotype initially diagnosed as CVID: new aspects of old diseases.","volume":"6","author":"Fran\u00e7a","year":"2018","journal-title":"Front Pediatr."},{"key":"B16","first-page":"101","article-title":"Immunodeficiency with hyper-IgM (HIM).","volume":"3","author":"Notarangelo","year":"1992","journal-title":"Immunodefic Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2141.2010.08077.x","article-title":"Update on the hyper immunoglobulin M syndromes.","volume":"149","author":"Davies","year":"2010","journal-title":"Br J Haematol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","article-title":"Clinical spectrum of X-linked hyper-IgM syndrome.","volume":"131","author":"Levy","year":"1997","journal-title":"J Pediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine (Baltimore)."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1182\/blood-2003-12-4420","article-title":"Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome.","volume":"105","author":"Lee","year":"2005","journal-title":"Blood."},{"key":"B21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4049\/jimmunol.155.2.556","article-title":"Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers.","volume":"155","author":"Han","year":"1995","journal-title":"J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1749-6632.1997.tb52088.x","article-title":"Analysis of CD40-CD40 ligand interactions in the regulation of human B cell function.","volume":"815","author":"Lipsky","year":"1997","journal-title":"Ann N Y Acad Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1006\/smim.1994.1038","article-title":"CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells.","volume":"6","author":"Aversa","year":"1994","journal-title":"Semin Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency.","volume":"35","author":"Al-Herz","year":"2015","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/clinids\/23.5.1188","article-title":"Visceral leishmaniasis in a patient with hyper-IgM hypogammaglobulinemia.","volume":"23","author":"Mart\u00edn","year":"1996","journal-title":"Clin Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10875-016-0270-9","article-title":"Visceral leishmaniasis may unmask X-linked hyper-IgM syndrome.","volume":"36","author":"Gonzalez-Granado","year":"2016","journal-title":"J Clin Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.smim.2009.06.003","article-title":"CD40 and the immune response to parasitic infections.","volume":"21","author":"Subauste","year":"2009","journal-title":"Semin Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cellimm.2016.06.004","article-title":"Pathways leading to interleukin-12 production and protective immunity in cutaneous leishmaniasis.","volume":"309","author":"Okwor","year":"2016","journal-title":"Cell Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1046\/j.1365-2249.2000.01307.x","article-title":"Absence of CD40\u2013CD40 ligand interactions in X-linked hyper-IgM syndrome does not affect differentiation of T helper cell subsets.","volume":"121","author":"Uronen","year":"2000","journal-title":"Clin Exp Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s10875-011-9607-6","article-title":"Phenotypic heterogeneity in a family with a CD40 ligand intracellular domain mutation.","volume":"32","author":"Kiani-Alikhan","year":"2012","journal-title":"J Clin Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1136\/jcp.2008.058362","article-title":"Cerebral toxoplasmosis in a middle-aged man as first presentation of primary immunodeficiency due to a hypomorphic mutation in the CD40 ligand gene.","volume":"61","author":"Yong","year":"2008","journal-title":"J Clin Pathol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10875-007-9089-8","article-title":"Clinical follow-up of 11 Argentinian CD40L-deficient patients with 7 unique mutations including the so-called \u201cmilder\u201d mutants.","volume":"27","author":"Danielian","year":"2007","journal-title":"J Clin Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1086\/515633","article-title":"Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome.","volume":"178","author":"Seyama","year":"1998","journal-title":"J Infect Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/1753425917739681","article-title":"Prospects for modulating the CD40\/CD40L pathway in the therapy of the hyper-IgM syndrome.","volume":"24","author":"Meng","year":"2018","journal-title":"Innate Immun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/j.celrep.2018.04.103","article-title":"Site-specific gene editing of human hematopoietic stem cells for X-linked hyper-IgM syndrome.","volume":"23","author":"Kuo","year":"2018","journal-title":"Cell Rep."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.567856\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T06:11:42Z","timestamp":1696659102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.567856\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2020.567856"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.567856","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"article-number":"567856"}}